Squarepoint Ops LLC Blueprint Medicines Corp Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 224,210 shares of BPMC stock, worth $20.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

224,210

Previous 2,400 9242.08%

Holding current value

$20.3 Million

Previous $258,000 7934.88%

% of portfolio

0.03%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $18.9 Million - $27 Million	224,210 New	224,210 $20.7 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $142,694 - $301,358	3,246 New	3,246 $299,000
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $1.84 Million - $2.43 Million	48,526 Added 313.82%	63,989 $2.88 Million
Q4 2022 Feb 14, 2023	SELL	$41.06 - $66.48 $455,026 - $736,731	-11,082 Reduced 41.75%	15,463 $677,000
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $2.2 Million - $3.43 Million	-44,108 Reduced 62.43%	26,545 $1.75 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $2.83 Million - $4.38 Million	62,471 Added 763.52%	70,653 $3.57 Million
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $281,590 - $572,966	-5,205 Reduced 38.88%	8,182 $523,000
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $1.26 Million - $1.55 Million	13,387 New	13,387 $1.43 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $1.33 Million - $1.8 Million	-14,426 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $882,522 - $1.23 Million	-13,281 Reduced 47.93%	14,426 $1.34 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $1.58 Million - $2.2 Million	27,707 New	27,707 $2.16 Million
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $1.86 Million - $2.3 Million	-27,810 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$72.9 - $101.41 $521,016 - $724,777	7,147 Added 34.59%	27,810 $2.04 Million
Q2 2019 Aug 14, 2019	SELL	$73.54 - $97.8 $1.05 Million - $1.39 Million	-14,224 Reduced 40.77%	20,663 $1.95 Million
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $1.33 Million - $2.36 Million	27,272 Added 358.14%	34,887 $2.79 Million
Q4 2018 Feb 14, 2019	SELL	$45.57 - $74.26 $58,557 - $95,424	-1,285 Reduced 14.44%	7,615 $411,000
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $318,114 - $422,927	5,400 Added 154.29%	8,900 $695,000
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $213,360 - $354,130	3,500 New	3,500 $222,000
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $582,576 - $818,452	-7,950 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $500,134 - $702,144	7,950	7,950 $600,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Blueprint Medicines Corp Transaction History